Skip to main content

Table 3 Pearson’s correlation matrix of the descriptors in the selected model

From: In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

  AATSC8c MATS8c SpMAD_Dzs BCUTc-1 l
AATSC8c 1    
MATS8c 0.989573 1   
SpMAD_Dzs 0.194418 0.168297 1  
BCUTc-1l − 0.1423 -0.12496 0.000392 1